dicloxacillin sodium capsule
stat rx usa llc - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin sodium 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staph
dicloxacillin sodium capsule
redpharm drug inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i
dicloxacillin sodium capsule
liberty pharmaceuticals, inc. - dicloxacillin sodium (unii: 4hzt2v9kx0) (dicloxacillin - unii:cof19h7wbk) - dicloxacillin 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of dicloxacillin sodium capsules usp and other antibacterial drugs, dicloxacillin sodium capsules usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. dicloxacillin is indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. cultures and susceptibility tests should be performed initially to determine the causative organisms and their sensitivity to the drug. (see clinical pharmacology – susceptibility plate testing ). dicloxacillin may be used to initiate therapy in suspected cases of resistant staphylococcal i
flucloxacillin (aft)
aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg; - capsule - 250 mg - active: flucloxacillin sodium monohydrate 272.6mg equivalent to flucloxacillin 250 mg excipient: colloidal silicon dioxide gelatin magnesium stearate
flucloxacillin (aft)
aft pharmaceuticals ltd - flucloxacillin sodium monohydrate 545.3mg equivalent to flucloxacillin 500 mg; - capsule - 500 mg - active: flucloxacillin sodium monohydrate 545.3mg equivalent to flucloxacillin 500 mg excipient: colloidal silicon dioxide gelatin magnesium stearate
cloxacillin - medo 500 mg
a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 500 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections:respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci.cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.
cloxacillin - medo 1 gr
a.l. medi-market ltd. - cloxacillin as sodium - powder for solution for inj/inf - cloxacillin as sodium 1000 mg/vial - cloxacillin - cloxacillin is indicated for the treatment of sensitive staphylococcal infections: respiratory infections, otorhinolaryngologic infections, renal infections, urogenital infections, neuro-meningeal infections, bone and joint infections, endocarditis, and treatment of skin infections caused by sensitive staphylococci and/or streptococci. cloxacillin is also indicated as preventive treatment of postoperative infections in neurosurgery.
orbenin l.a. lactating cow intramammary antibiotic infusion with prolonged action
zoetis australia pty ltd - cloxacillin as sodium cloxacillin - misc. intra mammary - cloxacillin as sodium cloxacillin active 200.0 mg/3gsy - antibiotic & related
cloxacillin for injection powder for solution
sterimax inc - cloxacillin (cloxacillin sodium) - powder for solution - 500mg - cloxacillin (cloxacillin sodium) 500mg - penicillinase-resistant penicillins
cloxacillin for injection powder for solution
sterimax inc - cloxacillin (cloxacillin sodium) - powder for solution - 1g - cloxacillin (cloxacillin sodium) 1g - penicillinase-resistant penicillins